{"id":"10184967810-77","name":"LEO Pharma A/S","registrationDate":"2012-01-23T13:41:17.428+01:00","category":2,"subCategory":3,"legal":"Limited company","web":"http://www.leo-pharma.com/","country":"Denmark","headAddress":"Industriparken, 55","headCity":"Ballerup","headPostCode":"2750","headPhone":"(45)44 94 58 88","boss":"Gitte Pugholm Aabo","bossTitle":"Ms","bossPosition":"CEO","membersCount":4,"membersFTE":"2.25","membership":"Member of the ​The Danish Association of the Pharmaceutical Industry (Lif)&#xd;\nMember of the International Federation of Pharmaceutical Manufactuers &amp; Associations (IFPMA)&#xd;\nMember of EFPIA","memberOrga":"","goal":"Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company.&#xd;<br />&#xd;<br />LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs. &#xd;<br />&#xd;<br />LEO Pharma has its own sales forces in 61 countries and employs around 4,800 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation.&#xd;<br />&#xd;<br />LEO Pharma’s revenue in 2013 amounted to DKK 7,842 million. The revenue decreased by 5% in Danish kroner compared to 2012. LEO Pharma's 2013 profit after tax 2012 amounted to 1,175 million DKK against 663 million DKK in 2012.","acronym":"LEO Pharma","interests":"Consumer Affairs, External Relations, Public Health, Research and Technology, Trade","euInitiatives":"REACH&#xd;<br />Incentives Review","lastUp":"2017-05-03T18:18:39.702+01:00","customers":"","costAbsolu":"","costRange":"","turnoverAbsolu":0,"turnoverRange":""}